MRI predictors of cognitive outcome in early multiple sclerosis

M S A Deloire1, A Ruet, D Hamel

  • 1INSERM U 1049, University Victor Segalen, case 78, 146 rue Léo Saignat, 33076 Bordeaux cedex, France.

Neurology
|March 30, 2011
PubMed
Abstract

Insights

Early multiple sclerosis (MS) patients show cognitive decline. Baseline diffuse brain damage and progressive central brain atrophy over two years predict long-term memory and information processing speed changes.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Relapsing-remitting multiple sclerosis (MS) is characterized by neurological deficits and cognitive impairment.
  • Early detection of predictors for cognitive decline in MS is crucial for timely intervention.
  • Magnetic Resonance Imaging (MRI) offers insights into brain changes associated with MS progression.

Purpose of the Study:

  • To identify MRI-based predictors of cognitive outcomes in patients diagnosed with early relapsing-remitting MS.
  • To assess the relationship between baseline and evolving MRI parameters and cognitive function over seven years.

Main Methods:

  • A cohort of 44 early MS patients underwent clinical, cognitive, and brain MRI assessments (including magnetization transfer imaging) at baseline, 2, 5, and 7 years.
  • MRI parameters analyzed included lesion load, brain parenchymal fraction (BPF), ventricular fraction (VF), and mean magnetization transfer ratio (MTR) in normal-appearing brain tissue (NABT).
  • Cognitive testing utilized the Brief Repeatable Battery, with comparisons to 56 healthy controls at baseline.

Main Results:

  • MS patients exhibited baseline deficits in memory, attention, and information processing speed (IPS).
  • Significant deterioration in MRI parameters was observed over two years, alongside worsening Expanded Disability Status Scale scores over seven years.
  • Memory decline over seven years correlated with baseline NABT MTR (diffuse brain damage); IPS decline correlated with baseline BPF (global atrophy), baseline diffuse brain damage, and 2-year VF change (central atrophy).

Conclusions:

  • Baseline diffuse brain damage, quantified by NABT MTR, is a key predictor of memory decline in early MS.
  • Progressive central brain atrophy, indicated by VF changes over two years, also predicts long-term cognitive impairment.
  • These MRI markers provide valuable prognostic information for cognitive outcomes in early MS.